Medivolve Inc.

$0.03+50.00%(+$0.01)
TickerSpark Score
61/100
Mixed
100
Valuation
65
Profitability
55
Growth
36
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEDV.NE research report →

52-Week Range14% of range
Low $0.01
Current $0.03
High $0.13

Companywww.medivolve.ca

Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology.

CEO
David Preiner
IPO
2010
Employees
25
HQ
Toronto, ON, CA

Price Chart

-75.00% · this period
$0.13$0.07$0.01Feb 22Aug 23Feb 22

Valuation

Market Cap
$810.58K
P/E
-0.05
P/S
1.18
P/B
-0.05
EV/EBITDA
-0.61
Div Yield
0.00%

Profitability

Gross Margin
78.26%
Op Margin
-521.52%
Net Margin
-2397.55%
ROE
213.22%
ROIC
25.23%

Growth & Income

Revenue
$686.45K · -50.54%
Net Income
$-16,458,000 · 10.38%
EPS
$-0.14 · 79.41%
Op Income
$-3,580,000
FCF YoY
-151.83%

Performance & Tape

52W High
$0.13
52W Low
$0.01
50D MA
$0.02
200D MA
$0.04
Beta
2.78
Avg Volume
43.74K

Get TickerSpark's AI analysis on MEDV.NE

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our MEDV.NE Coverage

We haven't published any research on MEDV.NE yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate MEDV.NE Report →

Similar Companies